Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.66
Delayed Data
As of 3:59pm ET
 +0.11 / +1.46%
Today’s Change
6.15
Today|||52-Week Range
11.34
-14.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues617.0K618.0K611.0K604.0K
 
 
 
 
 
Depreciation And Amortization2.0K1.0K1.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income615.0K------
 
 
General Expenses2.8M3.5M3.3M3.7M
 
 
 
 
 
Research And Development2.3M2.5M2.3M2.7M
 
 
 
 
 
Total Operating Expenses2.8M3.5M3.3M3.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-2.9M-2.7M-3.1M
 
 
 
 
 
Other Expenses-20.0K-36.0K-21.0K-22.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.0M-2.7M-2.5M-2.9M
 
 
 
 
 
Net Income-2.0M-2.7M-2.5M-2.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.3M13.5M14.2M14.4M
 
 
 
 
 
Shares To Calculate EPS Diluted13.3M13.5M14.2M14.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15---$0.18-$0.20
 
 
 
 
EPS Diluted-$0.15-$0.20-$0.18-$0.20